Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Pharm Educ. 2010 Feb 10;74(1):4.

Didactic migraine education in US doctor of pharmacy programs.

Author information

1
Diamond Headache Clinic Inpatient Unit, St. Joseph Hospital, Chicago, IL 60657, USA. rich.wenzel@hotmail.com

Abstract

OBJECTIVE:

To compare didactic migraine education in doctor of pharmacy (PharmD) programs in the United States with the Headache Consortium's evidence-based migraine treatment recommendations.

METHODS:

A self-administered survey instrument was mailed to all 90 Accreditation Council for Pharmacy Education (ACPE) approved PharmD programs in the United States.

RESULTS:

Seventy-seven programs responded (86%) and 69 useable survey instruments were analyzed. Fifty-five percent of programs discussed the Consortium's guidelines, 49% discussed the selection of nonprescription versus prescription agents, 45% recommended a butalbital-containing product as migraine treatment, and 20% educated students about tools for assessing migraine-related debilitation. At least 50% of programs taught information consistent with the remaining Consortium recommendations.

CONCLUSION:

Approximately half of the PharmD programs teach concepts about migraine headache treatment consistent with the US Headache Consortium's recommendations.

KEYWORDS:

evidence-based; headache; migraine; pharmacy education

PMID:
20221355
PMCID:
PMC2829152
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center